Abstract:Clostridioides difficile is a spore-forming pathogen and the most common cause of healthcare-associated diarrhea and colitis in the United States. Besides producing the main virulence factors, toxin A (TcdA) and toxin B (TcdB), many of the common clinical strains encode the C . difficile transferase (CDT) binary toxin. The role of CDT in the context of C . difficile infection (CDI) is poorly understood. Inflammation is a hallmark of CDI and multiple mechanisms of inflammasome activation have been reported for TcdA, TcdB, and the organism. Some studies have suggested that CDT contributes to this inflammation through a TLR2-dependent priming mechanism that leads to the suppression of protective eosinophils. Here, we show that CDT does not prime but instead activates the inflammasome in bone marrow-derived dendritic cells (BMDCs). In bone marrow-derived macrophages (BMDMs), the cell binding and pore-forming component of the toxin, CDTb, alone activates the inflammasome and is dependent on K + efflux. The activation is not observed in the presence of CDTa and is not observed in BMDMs derived from Nlrp3 -/- mice suggesting the involvement of the NLRP3 inflammasome. However, we did not observe evidence of CDT-dependent inflammasome priming or activation in vivo . Mice were infected with R20291 and an isogenic CRISPR/Cas9-generated R20291 Δ cdtB strain of C . difficile . While CDT contributes to increased weight loss and cecal edema at 2 days post infection, the relative levels of inflammasome-associated cytokines, IL-1β and IL-18, in the cecum and distal colon are unchanged. We also saw CDT-dependent weightloss in Nlrp3 -/- mice, suggesting that the increased weightloss associated with the presence of CDT is not a result of NLRP3-dependent inflammasome activation. This study highlights the importance of studying gene deletions in the context of otherwise fully isogenic strains and the challenge of translating toxin-specific cellular responses into a physiological context, especially when multiple toxins are acting at the same time. Clostridioides difficile is a pathogen causing life-threatening diarrhea. C . difficile transferase (CDT) toxin is present in many strains associated with severe disease but its role during C . difficile infection is unclear. In this study, we show that the pore forming subunit, CDTb, activates the inflammasome in myeloid-derived murine cells. While we found that CDT contributes to weight loss in a C . difficile mouse infection model, this was independent of the inflammasome function. This study highlights the importance of studying gene deletions in the context of otherwise fully isogenic strains and the challenge of translating findings in tissue culture models to animal infections. However, it does reveal an additive role for CDT in the tissue edema that occurs in the murine model of acute infection and is consistent with the idea that CDT contributes to the severity of CDI symptoms.

C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation

TcdB from Hypervirulent Clostridioides difficile Induces Neuronal Loss and Neurotransmitter Alterations in the Intrinsic Enteric Nervous System

Purified CDT toxins and a clean deletion within the CDT locus provide novel insights into the contribution of binary toxin in cellular inflammation and Clostridioides difficile infection

Clostridioides Difficile Aggravates Dextran Sulfate Solution (Dss)-Induced Colitis by Shaping the Gut Microbiota and Promoting Neutrophil Recruitment

Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Chondroitin Sulfate Proteoglycan 4 Functions As the Cellular Receptor for Clostridium Difficile Toxin B.

Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells

Clostridioides difficile Toxins: Host Cell Interactions and Their Role in Disease Pathogenesis

Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection

Cysteine Protease-Mediated Autocleavage of Clostridium Difficile Toxins Regulates Their Proinflammatory Activity

Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways

Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology

Inhibition of EGFR/ErbB does not protect against C. difficile toxin B

Protection Against Clostridioides Difficile Disease by a Naturally Avirulent C. Difficile Strain

Structural Basis for CSPG4 As a Receptor for TcdB and a Therapeutic Target in Clostridioides Difficile Infection

Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling

PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells

Blocking Toxin Function and Modulating the Gut Microbiota: Caffeic Acid and Its Derivatives As Potential Treatments for Clostridioides Difficile Infection

CSPG4-dependent cytotoxicity for C. difficile TcdB is influenced by extracellular calcium and chondroitin sulfate

Clostridium Difficile Toxin B-induced Colonic Inflammation is Mediated by the FOXO3/PPM1B Pathway in Fetal Human Colon Epithelial Cells.

Critical Roles of Clostridium Difficile Toxin B Enzymatic Activities in Pathogenesis